The more detailed analysis in Table 2 demonstrates that the physicians' preference of generic products was confined to general practitioners.
We cannot directly measure the physicians' preferences; therefore, we will use the prescriptions they issued to their previous patients as a proxy for their preferences.
The results showed that patients who consult for MSDs were comparable for quality of life and co-morbidities regardless of the physicians' preferences for prescribing homeopathy or CAMs.
The study objective was to estimate the effect of physician preference on the risk of discontinuation.
Nor did the reason for the inappropriate caesarean (physician preference vs. maternal request) differ between level I and level II, again each compared with the level III hospital (Table 3).
To assess the effect of physician preference for a particular tumour necrosis factor α (TNF) antagonist on the risk of treatment discontinuation in rheumatoid arthritis.
Within-physician variation in prescribing decisions and the effect of physician preference have infrequently been studied.
Despite an association with new prescribing decisions, the role of physician preference in treatment discontinuation has not been studied.
While the effect of physician preference on discontinuation has not been previously studied in this therapeutic class or in other conditions, physician preference was found to be an important predictor of drug selection in treatment initiation.
Sensitivity analysis was conducted to examine the robustness of main results, using thresholds of 70% or 80% for the level of physician preference.
